Titlebook: Handbook of Evidence-Based Stereotactic Radiosurgery and Stereotactic Body Radiotherapy; Rajni A. Sethi,Igor J. Barani,Mack Roach III Book

Culmination

負(fù)擔(dān)

Peter Ramu,Mathis Grenacher,Bruno Thürlimann stereotactic outcomes are superior to conventionally fractionated strategies for both primary and metastatic tumors alike. Optimal dose and fractionation, dose-limiting toxicities, and treatment precision are ongoing areas of controversy and investigation.

FLUSH

Introduction to Stereotactic Radiosurgery and Stereotactic Body Radiotherapy,ong with the development of megavoltage treatment machines, imaging-based treatment planning, and intensity-modulated radiation therapy. This chapter outlines the historical foundations and development of SRS and SBRT technologies.

Oligarchy

恃強(qiáng)凌弱

https://doi.org/10.1007/978-3-663-14270-6pecially for lesions less suited to resection or radiofrequency ablation (RFA). Retrospective studies have demonstrated excellent local control of metastases in the lung, spine, liver, and brain, with some series suggesting a survival benefit in patients with oligometastatic disease in particular.

Pde5-Inhibitors

Repatriate